• News
  • SAN DIEGO
  • Finance

Pfizer Q4 net jumps on sale of nutrition business

Drugmaker Pfizer Inc.'s fourth-quarter results easily beat Wall Street expectations, driving up its stock, as profit more than quadrupled, due to tighter spending and a $4.8 billion gain from selling its nutrition business.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!